Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,346.00
Bid: 12,376.00
Ask: 12,380.00
Change: 156.00 (1.28%)
Spread: 4.00 (0.032%)
Open: 12,304.00
High: 12,380.00
Low: 12,088.00
Prev. Close: 12,190.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK shares weaken, Tullow loses half its market cap

Mon, 09th Dec 2019 09:23

* FTSE 100, FTSE 250 down 0.1%

* Tesco outshines the main index

* Some domestic stocks gain on election optimism

* Tullow Oil plummets after co cancels dividend, CEO exits
(Adds company news items, updates share moves)

By Muvija M and Shashwat Awasthi

Dec 9 (Reuters) - London's exporter-heavy FTSE 100 inched
lower on Monday as oil majors and Asia-exposed financials fell
on China growth worries and as the pound strengthened, while a
72% slump in Tullow Oil single-handedly dragged down midcaps.

The blue-chip index was gave up 0.1%, with its
dollar earners including spirits company Diageo and
pharmaceutical giant AstraZeneca taking a hit from gains
in sterling ahead of UK general election later this week.

The FTSE 250 midcap index was also down by the same
level, with Tullow Oil recording its steepest one-day
fall since early 2004 after the oil and gas explorer scrapped
dividend and announced the exit of its CEO.

Monday's drop wiped off roughly half of Tullow's market cap,
or 1 billion pounds ($1.28 billion), as the stock tumbled to its
lowest in 15-1/2 years. Rival Premier Oil also fell 8%.

Other news-related moves saw Tesco top the bluechip
index with a 5% rise after the retailer started a review of its
operations in Thailand and Malaysia.

Helping limit losses on the midcap bourse was engineering
firm Senior Plc, which jumped 7% on news that it was
reviewing options for its aerostructures business. Marks &
Spencer added 3.5% after a double upgrade from Goldman
Sachs.

Elsewhere, China's exports in November shrank for the fourth
consecutive month, fanning worries over the impact of the
Sino-U.S. trade war on the world's second-largest economy and
overshadowing Friday's strong U.S. jobs data.

"The contrasting U.S. and Chinese data should swing the
trade negotiation pendulum back to neutral from the Chinese side
amongst the world's trade watchers," OANDA analyst Jeffrey
Halley said.

Investors were also trying to size up the chances of a new
round of U.S. tariffs on $156 billion worth of Chinese goods
from Dec. 15.

While signs of progress in the trade negotiations lifted the
FTSE 100 to its biggest one-day gain since July on Friday, the
bourse still marked its steepest weekly fall after contradictory
messages from U.S. President Donald Trump earlier on.

"More soothing noises on the negotiations emerged from
Washington D.C. on Friday, but one gets the sense that this
Sunday's next round of tariffs on China is no longer the line in
the sand it once was perceived to be," Halley said.

On Monday, some of Britain's more domestically-exposed firms
such as Lloyds and Barclays outperformed as
investors bet on the Boris Johnson-led Conservatives to win the
election this week and deliver Brexit.

"Three days to polling day and the polls are looking good
for Boris Johnson..., although the spectre of tactical voting
still lingers," Raymond James analyst Chris Bailey said.

($1 = 0.7794 pounds)

(Reporting by Muvija M and Shashwat Awasthi in Bengaluru with
additional reporting by Tanishaa Nadkar; Editing by Arun Koyyur
and Mark Heinrich)

More News
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.